Kristal Artropatilere Algoritmik Yaklaşım
Özet
Referanslar
Bodofsky, Shari, Tony R. Merriman, T. J. Thomas, and Naomi Schlesinger. “Advances in Our Understanding of Gout as an Auto-Inflammatory Disease.” Seminars in Arthritis and Rheumatism 50, no. 5 (2020): 1089–100. https://doi.org/10.1016/j.semarthrit.2020.06.015.
FitzGerald, John D. “Gout.” Annals of Internal Medicine 178, no. 3 (2025): ITC33–48. https://doi.org/10.7326/ANNALS-24-03951.
FitzGerald, John D., Nicola Dalbeth, Ted Mikuls, et al. “2020 American College of Rheumatology Guideline for the Management of Gout.” Arthritis Care & Research 72, no. 6 (2020): 744–60. https://doi.org/10.1002/acr.24180.
Lai, Kuo-Lung, and Ying-Ming Chiu. “Role of Ultrasonography in Diagnosing Gouty Arthritis.” Journal of Medical Ultrasound 19, no. 1 (2011): 7–13. https://doi.org/10.1016/j.jmu.2011.01.003.
Mandl, Peter, Maria Antonietta D’Agostino, Victoria Navarro-Compán, et al. “2023 EULAR Recommendations on Imaging in Diagnosis and Management of Crystal-Induced Arthropathies in Clinical Practice.” Annals of the Rheumatic Diseases 83, no. 6 (2024): 752–59. https://doi.org/10.1136/ard-2023-224771.
Neogi, Tuhina, Tim L. Th A. Jansen, Nicola Dalbeth, et al. “2015 Gout Classification Criteria: An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative.” Arthritis & Rheumatology (Hoboken, N.J.) 67, no. 10 (2015): 2557–68. https://doi.org/10.1002/art.39254.
Tong, Shuting, Peiyu Zhang, Qi Cheng, et al. “The Role of Gut Microbiota in Gout: Is Gut Microbiota a Potential Target for Gout Treatment.” Frontiers in Cellular and Infection Microbiology 12 (November 2022): 1051682. https://doi.org/10.3389/fcimb.2022.1051682.
Xu, Ying-Xi, Lu-Di Liu, Jiang-Yuan Zhu, et al. “Alistipes Indistinctus-Derived Hippuric Acid Promotes Intestinal Urate Excretion to Alleviate Hyperuricemia.” Cell Host & Microbe 32, no. 3 (2024): 366-381.e9. https://doi.org/10.1016/j.chom.2024.02.001.
Kalsiyum Pirofosfat Depolama Hastalığı
Abhishek, A., Tedeschi, S. K., Pascart, T., et al. “The 2023 American College of Rheumatology/European Alliance of Associations for Rheumatology Classification Criteria for Calcium Pyrophosphate Deposition (CPPD) Disease.” Annals of the Rheumatic Diseases 82, no. 10 (2023): 1248–1257. https://doi.org/10.1136/ard-2023-224575.
Mandl, P., D’Agostino, M. A., Navarro-Compán, V., et al. “2023 EULAR recommendations on imaging in diagnosis and management of crystal-induced arthropathies in clinical practice.” Annals of the Rheumatic Diseases 83, no. 6 (2024): 752–759. https://doi.org/10.1136/ard-2023-224771.
Oliviero, F., Scanu, A., Galozzi, P., et al. “Prevalence of calcium pyrophosphate and monosodium urate crystals in synovial fluid of patients with previously diagnosed joint diseases.” Joint Bone Spine 80, no. 3 (2013): 287–290. https://doi.org/10.1016/j.jbspin.2012.08.006.
Pascart, T., Filippou, G., Lioté, F., et al. “Calcium pyrophosphate deposition disease.” The Lancet Rheumatology 6, no. 11 (2024): e791–e804. https://doi.org/10.1016/S2665-9913(24)00122-X.
Rosenthal, A. K., Ryan, L. M. “Calcium Pyrophosphate Deposition Disease.” The New England Journal of Medicine374, no. 26 (2016): 2575–2584. https://doi.org/10.1056/NEJMra1511117.
Williams, C. J., Rosenthal, A. K. “Pathogenesis of calcium pyrophosphate deposition disease.” Best Practice & Research Clinical Rheumatology 35, no. 4 (2021): 101718. https://doi.org/10.1016/j.berh.2021.101718.
Zhang, W., Doherty, M., Bardin, T., et al. “European League Against Rheumatism recommendations for calcium pyrophosphate deposition. Part I: Terminology and diagnosis.” Annals of the Rheumatic Diseases 70, no. 4 (2011): 563–570. https://doi.org/10.1136/ard.2010.139105.
Referanslar
Bodofsky, Shari, Tony R. Merriman, T. J. Thomas, and Naomi Schlesinger. “Advances in Our Understanding of Gout as an Auto-Inflammatory Disease.” Seminars in Arthritis and Rheumatism 50, no. 5 (2020): 1089–100. https://doi.org/10.1016/j.semarthrit.2020.06.015.
FitzGerald, John D. “Gout.” Annals of Internal Medicine 178, no. 3 (2025): ITC33–48. https://doi.org/10.7326/ANNALS-24-03951.
FitzGerald, John D., Nicola Dalbeth, Ted Mikuls, et al. “2020 American College of Rheumatology Guideline for the Management of Gout.” Arthritis Care & Research 72, no. 6 (2020): 744–60. https://doi.org/10.1002/acr.24180.
Lai, Kuo-Lung, and Ying-Ming Chiu. “Role of Ultrasonography in Diagnosing Gouty Arthritis.” Journal of Medical Ultrasound 19, no. 1 (2011): 7–13. https://doi.org/10.1016/j.jmu.2011.01.003.
Mandl, Peter, Maria Antonietta D’Agostino, Victoria Navarro-Compán, et al. “2023 EULAR Recommendations on Imaging in Diagnosis and Management of Crystal-Induced Arthropathies in Clinical Practice.” Annals of the Rheumatic Diseases 83, no. 6 (2024): 752–59. https://doi.org/10.1136/ard-2023-224771.
Neogi, Tuhina, Tim L. Th A. Jansen, Nicola Dalbeth, et al. “2015 Gout Classification Criteria: An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative.” Arthritis & Rheumatology (Hoboken, N.J.) 67, no. 10 (2015): 2557–68. https://doi.org/10.1002/art.39254.
Tong, Shuting, Peiyu Zhang, Qi Cheng, et al. “The Role of Gut Microbiota in Gout: Is Gut Microbiota a Potential Target for Gout Treatment.” Frontiers in Cellular and Infection Microbiology 12 (November 2022): 1051682. https://doi.org/10.3389/fcimb.2022.1051682.
Xu, Ying-Xi, Lu-Di Liu, Jiang-Yuan Zhu, et al. “Alistipes Indistinctus-Derived Hippuric Acid Promotes Intestinal Urate Excretion to Alleviate Hyperuricemia.” Cell Host & Microbe 32, no. 3 (2024): 366-381.e9. https://doi.org/10.1016/j.chom.2024.02.001.
Kalsiyum Pirofosfat Depolama Hastalığı
Abhishek, A., Tedeschi, S. K., Pascart, T., et al. “The 2023 American College of Rheumatology/European Alliance of Associations for Rheumatology Classification Criteria for Calcium Pyrophosphate Deposition (CPPD) Disease.” Annals of the Rheumatic Diseases 82, no. 10 (2023): 1248–1257. https://doi.org/10.1136/ard-2023-224575.
Mandl, P., D’Agostino, M. A., Navarro-Compán, V., et al. “2023 EULAR recommendations on imaging in diagnosis and management of crystal-induced arthropathies in clinical practice.” Annals of the Rheumatic Diseases 83, no. 6 (2024): 752–759. https://doi.org/10.1136/ard-2023-224771.
Oliviero, F., Scanu, A., Galozzi, P., et al. “Prevalence of calcium pyrophosphate and monosodium urate crystals in synovial fluid of patients with previously diagnosed joint diseases.” Joint Bone Spine 80, no. 3 (2013): 287–290. https://doi.org/10.1016/j.jbspin.2012.08.006.
Pascart, T., Filippou, G., Lioté, F., et al. “Calcium pyrophosphate deposition disease.” The Lancet Rheumatology 6, no. 11 (2024): e791–e804. https://doi.org/10.1016/S2665-9913(24)00122-X.
Rosenthal, A. K., Ryan, L. M. “Calcium Pyrophosphate Deposition Disease.” The New England Journal of Medicine374, no. 26 (2016): 2575–2584. https://doi.org/10.1056/NEJMra1511117.
Williams, C. J., Rosenthal, A. K. “Pathogenesis of calcium pyrophosphate deposition disease.” Best Practice & Research Clinical Rheumatology 35, no. 4 (2021): 101718. https://doi.org/10.1016/j.berh.2021.101718.
Zhang, W., Doherty, M., Bardin, T., et al. “European League Against Rheumatism recommendations for calcium pyrophosphate deposition. Part I: Terminology and diagnosis.” Annals of the Rheumatic Diseases 70, no. 4 (2011): 563–570. https://doi.org/10.1136/ard.2010.139105.
